Clinical Trial Update: An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons [NA]

View source ↗

Summary

This open-label trial studied whether valacyclovir affects plasma HIV-1 levels in HIV-1 seropositive, HSV-1/2 seronegative adults. The study has been withdrawn …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Valacyclovir (Valacyclovir)

Snippet

Sponsor: University of Washington | Conditions: HIV, HIV Infections | NA | Status: WITHDRAWN